Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimal drug and behavior therapy for treatment-refractory schizophrenic patients

R P Liberman1, T Van Putten, B D Marshall

  • 1Camarillo-UCLA Research Center, Camarillo State Hospital, CA 93011-6022.

The American Journal of Psychiatry
|May 1, 1994
PubMed
Summary

Reducing haloperidol dosage in long-term schizophrenic patients improved psychopathology and side effects. Intensive behavior therapy further enhanced functional behaviors like self-care and social interaction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ingestion of foreign bodies and caustic substances in children.

BJA education·2023
Same author

Anaesthetic management of children with epidermolysis bullosa.

BJA education·2021
Same author

Dynamics of Mixed- Candida Species Biofilms in Response to Antifungals.

Journal of dental research·2017
Same author

Evaluation of the accuracy of common weight estimation formulae in a Zambian paediatric surgical population.

Anaesthesia·2016
Same author

In-depth analysis of chloride treatments for thin-film CdTe solar cells.

Nature communications·2016
Same author

A Critical Role for Extracellular DNA in Dental Plaque Formation.

Journal of dental research·2016

Area of Science:

  • Psychiatry
  • Clinical Psychology

Background:

  • Schizophrenia is a chronic mental disorder often requiring long-term treatment.
  • Treatment-refractory schizophrenia presents challenges in managing symptoms and improving patient functioning.
  • High-dose antipsychotic medication, such as haloperidol, is frequently used but can lead to side effects.

Purpose of the Study:

  • To investigate the feasibility and effects of reducing haloperidol dosage in patients with treatment-refractory schizophrenia.
  • To assess the impact of adding behavior therapy to optimized haloperidol treatment on functional outcomes.

Main Methods:

  • A cohort of 13 treatment-refractory schizophrenic patients with prolonged hospitalization and high haloperidol doses (>50 mg/day) participated.
  • Patients underwent a mean haloperidol dose reduction of 63%.

Related Experiment Videos

  • Intensive behavior therapy was introduced to patients at their optimized haloperidol dose.

    • Main Results:

    • Patients successfully tolerated significant haloperidol dose reduction, reporting improvements in psychopathology and reduced side effects.
    • The addition of behavior therapy led to further enhancements in functional behaviors, including self-care and social interaction.
    • These findings suggest a potential for optimizing antipsychotic treatment and integrating behavioral interventions.

    Conclusions:

    • Haloperidol dose reduction is feasible and beneficial for select long-term, treatment-refractory schizophrenic patients.
    • Behavioral therapy complements pharmacotherapy, significantly improving functional outcomes in schizophrenia.
    • This approach offers a strategy for improving quality of life in patients with chronic schizophrenia.